BioSpace News Archive

Results support Xenleta as an empiric, short-course monotherapy replacement for respiratory fluoroquinolones for treatment of CABP

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the virtual BofA Securities 2020 Health Care Conference on Wednesday, May 13, 2020 at 9:40 a.m. EDT.

XOMA Corporation reported its first quarter 2020 financial results and provided a COVID-19 business update.

Rallybio LLC, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, announced the hiring of Rachael Alford, PhD to lead the Company’s Chemistry, Manufacturing and Controls operations.

SightGlass Vision, Inc. announced it will hold an R&D webinar to discuss the science of and latest research in myopia, as well as provide an overview about the clinical development and commercialization program for the Company’s novel glasses designed to slow the progression of myopia in children.

ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal technologies for treating patients with acute respiratory failure, announced the recent initiation of commercial development of its next generation artificial lung, which expands the Company’s focus on highly efficient gas exchange devices and also broadens its applicable market.

Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform, ImmTOR™, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will present at the Bank of America Merrill Lynch 2020 Health Care Conference, which is being held virtually, on Tuesday, May 12 at 5:00 p.m. Eastern Time. A live webcast an

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the Bank of America Securities 2020 Healthcare Conference, taking place virtually on Tuesday, May 12th, 2020 at 1:00 p.m. ET.

Patent covers first-of-its-kind solution that allows clinicians to perform procedures through ventilation mask without disrupting therapeutic pressure

Study examines if colchicine, a common gout medication, can reduce complications associated with COVID-19, slow disease progression, and save patient lives